TIMOTHY M. SHANNON

Corporate Board Profile

Tech Score: 0/100

Celldex Therapeutics, Inc.

Filing Date	Source Excerpt
2010-08-04	Timothy M. Shannon, M.D. became a director of Celldex in October 2009. On December 16, 2009, the Board of Directors granted to Dr. Shannon, as our new director, stock options to purchase 8,000 shares of our common stock. The following table summarizes the annual compensation for our non-employee directors during 2009. Timothy M. Shannon, M.D. 12,500 Fees Earned or Paid in Cash, 8,960 Stock Awards, 21,360 Option Awards, Total 42,820.
2011-04-26	Timothy M. Shannon, M.D. became a director of Celldex in October 2009. The following table summarizes the annual compensation for our non-employee directors during 2010. Timothy M. Shannon, M.D. 50,000 Fees Earned or Paid in Cash, 7,920 Stock Awards, Total 57,920.

Filing Date

Source Excerpt

2010-08-04

Timothy M. Shannon, M.D. became a director of Celldex in October 2009. On December 16, 2009, the Board of Directors granted to Dr. Shannon, as our new director, stock options to purchase 8,000 shares of our common stock. The following table summarizes the annual compensation for our non-employee directors during 2009. Timothy M. Shannon, M.D. 12,500 Fees Earned or Paid in Cash, 8,960 Stock Awards, 21,360 Option Awards, Total 42,820.

2011-04-26

Timothy M. Shannon, M.D. became a director of Celldex in October 2009. The following table summarizes the annual compensation for our non-employee directors during 2010. Timothy M. Shannon, M.D. 50,000 Fees Earned or Paid in Cash, 7,920 Stock Awards, Total 57,920.

Data sourced from SEC filings. Last updated: 2025-10-12